SCHEMBL24378832

SCHEMBL24378832

CC1CC2(CCN(CCC#N)CC2)C1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
PKM P14618 1/20 0.52
POLB P06746 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 3/20 0.36
JAK1 P23458 2/20 0.35
JAK2 O60674 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 5/20 0.33
TSHR P16473 3/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 1/20 0.33
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24378835 0.90 ALDH1A1 (0.44) ALDH1A1PKMPOLBSMN1; SMN2MAPT
SCHEMBL23588708 0.78 ALDH1A1 (0.56) ALDH1A1PKMPOLBSMN1; SMN2MAPT
SCHEMBL24378833 0.76 KDM1A (0.39) ALDH1A1PKMSMN1; SMN2MAPK1CYP1A2
SCHEMBL24378840 0.76 WNT1 (0.34) CYP1A2CYP2D6ALOX15
SCHEMBL4258249 0.75 ALDH1A1 (0.62) ALDH1A1PKMPOLBSMN1; SMN2MAPT
SCHEMBL12424325 0.75 ALDH1A1 (0.62) ALDH1A1PKMPOLBSMN1; SMN2MAPT
SCHEMBL15986991 0.73 ALOX15 (0.46) CYP1A2CYP2D6ALOX15
SCHEMBL24378839 0.73 HSD11B1 (0.42) ALDH1A1TSHRCYP1A2CYP2D6ALOX15
SCHEMBL15100017 0.72 TSHR (0.40) SMN1; SMN2GAATSHR
SCHEMBL24854834 0.72 ALDH1A1 (0.48) ALDH1A1PKMPOLBSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022083616-A1 QUINAZOLINE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF 贝达药业股份有限公司 2022-04-28 WO disclosed